- Nikfarjam M, Wilson JS, Smith RC, et al. Diagnosis and management of pancreatic exocrine insufficiency. MJA 2017;207(4):161-165.
- Imrie CW, Connett G, Hall RI, et al. Review article: enzyme supplementation in cystic fibrosis, chronic pancreatitis, pancreatic and periampullary cancer. Aliment Pharmacol Ther 2010;32(1):1-25.
- Columbia Surgery. The Pancreas Center. Pancreas Functions, Location & Disease. Available from: https://columbiasurgery.org/pancreas/pancreas-and-its-functions. Accessed date: 5 April 2022.
- NIH. Your Digestive System & How it Works. Available from: https://www.niddk.nih.gov/health-information/digestive-diseases/digestivesystem-how-it-works. Accessed date: 5 April 2022.
- MSD MANUAL. Pancreas – Digestive Disorders. Available from: https://www.msdmanuals.com/home/digestive-disorders/biology-of-the-digestive-system/pancreas#. Accessed date: 7 April 2022.
- Toouli J, Biankin AV, Oliver MR, et al. Management of pancreatic exocrine insufficiency: Australasian Pancreatic Club recommendations. Med J Aust 2010;193(8):461-467.
- Domínguez-Muñoz JE. Diagnosis and treatment of pancreatic exocrine insufficiency. Curr Opin in Gastro 2018;34(5):1-6.
- Mayo Clinic. Osteoporosis –Symptoms and causes. Available from: www.mayoclinic.org/diseases-conditions/osteoporosis/symptoms-causes/
syc-20351968. Accessed date: 7 April 2022.
- Santilli V, Bernetti A, Mangone M, et al. Clinical definition of sarcopenia. Clin Case Min Bone Metabol 2014;11(3):177-180.
Creon® 10000. Each capsule contains Pancreatin 150 mg. Reg. No.: 33/11.1/0340; Mauritius POM Reg. No.:
R7435/02/16; Namibia: Reg. No.: 04/11.1/1015. Creon® 25000. Each capsule contains Pancreatin 300 mg.
Reg. No.: 28/11.1/0645; Namibia: Reg. No.: 04/11.1/1016.
For full prescribing information refer to the Professional Information approved by the Medicines Regulatory Authority.
Abbott Laboratories S.A. (Pty) Ltd. 1940/014043/07. Abbott Place, 219 Golf Club Terrace, Constantia Kloof, 1709.
Publication date: July 2022. Promotional review number: SAF2235118.
